The Olympus NBI Virtual Reality app “The NBI Experience” is a gamified Virtual Reality simulation experience where you travel inside the bladder to visualize potentially cancerous lesions toggling between White Light and Narrow Band Imaging technology. The intention is twofold; to demonstrate how easy NBI is to use; to show the effectiveness of narrow band imaging to aid in the visualization of vascular lesions.
The app highlights the fact that Narrow Band Imaging is now on the AUA/SUO 2016 Non-Muscle Invasive Bladder Cancer Guideline as well as having qualified FDA Claims. NBI is recommended as enhanced cystoscopy to increase detection and decrease recurrence.
NBI is the world’s only patented endoscopic light technology that enables effective targeting of biopsies not seen under white light, without the use of dyes or drugs. NBI enhances visibility of vascular structures on the mucosal surface. Unlike white light, which uses all colors in the spectrum, NBI uses only blue and green. Blue and green light are strongly absorbed by hemoglobin and appear darker than normal tissue.
Studies* have shown that NBI visualized 17% additional patients with Non-Muscle Invasive Bladder Cancer, 24% additional tumors and 28% additional Carcinoma In Situ (CIS).
*Based on a weighted average, studies have shown that using NBI allows physicians to visualize lesion boundaries. NBI is not intended to replace histopathological sampling as a means of diagnosis.
The app highlights the fact that Narrow Band Imaging is now on the AUA/SUO 2016 Non-Muscle Invasive Bladder Cancer Guideline as well as having qualified FDA Claims. NBI is recommended as enhanced cystoscopy to increase detection and decrease recurrence.
NBI is the world’s only patented endoscopic light technology that enables effective targeting of biopsies not seen under white light, without the use of dyes or drugs. NBI enhances visibility of vascular structures on the mucosal surface. Unlike white light, which uses all colors in the spectrum, NBI uses only blue and green. Blue and green light are strongly absorbed by hemoglobin and appear darker than normal tissue.
Studies* have shown that NBI visualized 17% additional patients with Non-Muscle Invasive Bladder Cancer, 24% additional tumors and 28% additional Carcinoma In Situ (CIS).
*Based on a weighted average, studies have shown that using NBI allows physicians to visualize lesion boundaries. NBI is not intended to replace histopathological sampling as a means of diagnosis.
Show More
